Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction

AIMS: Spironolactone has been shown to improve outcomes in patients with heart failure (HF) with reduced ejection fraction (EF). We investigated whether the discharge use of spironolactone could be associated with better long‐term outcomes among patients with HF with mid‐range EF (HFmrEF). METHODS A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ESC Heart Fail
Hauptverfasser: Enzan, Nobuyuki, Matsushima, Shouji, Ide, Tomomi, Kaku, Hidetaka, Higo, Taiki, Tsuchihashi‐Makaya, Miyuki, Tsutsui, Hiroyuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Original Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7083406/
https://ncbi.nlm.nih.gov/pubmed/31951680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12571
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge